Stocks and Investing
Stocks and Investing
Thu, June 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Chris Carey Maintained (SMG) at Buy with Decreased Target to $130 on, Jun 2nd, 2022
Chris Carey of Wells Fargo, Maintained "The Scotts Miracle-Gro Company" (SMG) at Buy with Decreased Target from $145 to $130 on, Jun 2nd, 2022.
Chris has made no other calls on SMG in the last 4 months.
There are 4 other peers that have a rating on SMG. Out of the 4 peers that are also analyzing SMG, 2 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- W. Andrew Carter of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $116 on, Wednesday, May 4th, 2022
- Gaurav Jain of "Barclays" Downgraded from Buy to Hold and Decreased Target to $110 on, Thursday, April 21st, 2022
These are the ratings of the 2 analyists that currently disagree with Chris
- Jeffrey Zekauskas of "JP Morgan" Upgraded from Hold to Buy and Held Target at $130 on, Wednesday, May 4th, 2022
- Joseph Altobello of "Raymond James" Maintained at Strong Buy with Decreased Target to $125 on, Wednesday, May 4th, 2022
Contributing Sources